Research Summary
Research Summary
01/07/2025
Miranda Manier, BA
A recent phase 3 trial demonstrated that a personalized approach using ibrutinib-venetoclax therapy, based on measurable residual disease, improves progression-free survival and overall survival in patients...
01/07/2025
FDA Alert
FDA Alert
01/06/2025
Anthony Calabro, MA
Crinecerfont, a first-in-class therapy, improved androgen control and reduced reliance on high-dose glucocorticoids for patients with congenital adrenal hyperplasia.
01/06/2025
FDA Alert
FDA Alert
01/01/2025
Anthony Calabro, MA
The FDA has approved tirzepatide, the first-ever drug option to treat moderate to severe obstructive sleep apnea in adults with obesity.
01/01/2025
Respiratory Diseases Roundup
Respiratory Diseases Roundup
10/24/2024
Anthony Calabro, MA
In this respiratory disease roundup, researchers report on the efficacy of nirmatrelvir-ritonavir for treating Long COVID, the CDC updates recommendations on “triple threat” vaccines for respiratory virus...
10/24/2024
FDA Alert
FDA Alert
07/31/2024
Anthony Calabro, MA
The first orally disintegrating birth control tablet was designed for individuals who have trouble swallowing their medication.
07/31/2024
Conference Coverage
Conference Coverage
07/16/2024

Randall Hudspeth, PhD, MBA, MS, APRN-CNP, FRE, FAANP

Randall Hudspeth, PhD, MBA, MS, ...
Although more patients are seeking pain relief in primary care settings, practitioners may not have the experience in managing and treating patients with complex pain situations or may not be familiar with...
07/16/2024
research summary
research summary
06/18/2024
Leigh Precopio
In a recent retrospective cohort study, researchers examined changes in the medication regimens of patients with type 2 diabetes following the initiation of second-line therapy.
06/18/2024
Research summary
Research summary
05/23/2024

Jessica Ganga

Jessica Ganga
A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.
05/23/2024
FDA ALERT
FDA ALERT
01/29/2024
Anthony Calabro, MA
The once-monthly RNA interference injection medication received FDA approval based on results from the phase II PHYOX2 clinical trial and phase III PHYOX3 extension study.
01/29/2024
Research Summary
Research Summary
01/26/2024
Jessica Ganga
Researchers evaluated whether patients with atherosclerotic cardiovascular disease (ASCVD) are utilizing high-intensity statins in their routine care of the disease.
01/26/2024